BNGO
Bionano Genomics IncNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$13.31M
P/E Ratio
—
EPS
$-4.46
Beta
1.62
52W High
$5.50
52W Low
$1.06
50-Day MA
$1.22
200-Day MA
$1.61
Dividend Yield
—
Profit Margin
-109.90%
Forward P/E
—
PEG Ratio
—
About Bionano Genomics Inc
Bionano Genomics, Inc. is a life science instrumentation company in the genome analysis space. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $28.74M |
| Gross Profit (TTM) | $13.50M |
| EBITDA | $-23.37M |
| Operating Margin | -118.10% |
| Return on Equity | -73.80% |
| Return on Assets | -28.60% |
| Revenue/Share (TTM) | $3.82 |
| Book Value | $3.32 |
| Price-to-Book | 0.36 |
| Price-to-Sales (TTM) | 0.46 |
| EV/Revenue | 0.558 |
| EV/EBITDA | -0.17 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 3.60% |
| Shares Outstanding | $11.47M |
| Float | $10.30M |
| % Insiders | 7.40% |
| % Institutions | 10.12% |
Historical Volatility
HV 10-Day
48.80%
HV 20-Day
43.70%
HV 30-Day
45.29%
HV 60-Day
78.84%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($5.00 target)
1
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026